Clinical Practice Guideline for the Use of Systemic Testosterone for HSDD published
- Created: Friday, 02 April 2021
ISSWSH publishes Clinical Practice Guideline for the Use of Systemic Testosterone for HSDD, an in-depth, detailed evidence-based, peer-reviewed international guideline on how healthcare professionals should administer testosterone to postmenopausal women.
This publication is so important that it appears simultaneously in three academic journals: The Journal of Sexual Medicine; Climacteric, and The Journal of Women’s Health. Although women naturally produce significant quantities of testosterone from puberty on, by the time they reach menopause, about 50% of their body’s testosterone has been lost. Such deficiency leads to reduced muscle mass and strength, increased body fat, and not infrequently to the sexual dysfunction commonly referred to as lost libido. Read the full press release here.